[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053830":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":7,"locations":20,"responsibleParty":7,"collaborators":79,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":7,"eligibilityCriteria":89,"healthyVolunteers":85,"sex":90,"minAge":91,"maxAge":92,"enrollmentInfo":93,"targetDuration":7,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":103,"overallStatus":106,"whyStopped":7,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":7,"completionDateStruct":7,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH",null,[9],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"DRUG","Methylprednisolone",[13,16,18],{"name":14,"affiliation":7,"role":15},"Dankner WM","STUDY_CHAIR",{"name":17,"affiliation":7,"role":15},"Bozzette S",{"name":19,"affiliation":7,"role":15},"Spector SA",[21,34,44,54,63,69],{"facility":22,"status":7,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":7},"UCSD Med Ctr \u002F Pediatrics \u002F Clinical Sciences","La Jolla","California","920930672","United States","US",{"type":29,"coordinates":30},"Point",[31,32],-117.2742,32.84727,{"lat":32,"lon":31},{"facility":35,"status":7,"city":36,"state":37,"zip":38,"country":26,"countryCode":27,"cosmosGeoPoint":39,"geoPoint":43,"contacts":7},"Chicago Children's Memorial Hosp","Chicago","Illinois","606143394",{"type":29,"coordinates":40},[41,42],-87.65005,41.85003,{"lat":42,"lon":41},{"facility":45,"status":7,"city":46,"state":47,"zip":48,"country":26,"countryCode":27,"cosmosGeoPoint":49,"geoPoint":53,"contacts":7},"St Louis Univ School of Medicine","St Louis","Missouri","63104",{"type":29,"coordinates":50},[51,52],-90.19789,38.62727,{"lat":52,"lon":51},{"facility":55,"status":7,"city":56,"state":56,"zip":57,"country":26,"countryCode":27,"cosmosGeoPoint":58,"geoPoint":62,"contacts":7},"Bellevue Hosp \u002F New York Univ Med Ctr","New York","10016",{"type":29,"coordinates":59},[60,61],-74.00597,40.71427,{"lat":61,"lon":60},{"facility":64,"status":7,"city":56,"state":56,"zip":65,"country":26,"countryCode":27,"cosmosGeoPoint":66,"geoPoint":68,"contacts":7},"Columbia Presbyterian Med Ctr","10032",{"type":29,"coordinates":67},[60,61],{"lat":61,"lon":60},{"facility":70,"status":7,"city":71,"state":72,"zip":73,"country":26,"countryCode":27,"cosmosGeoPoint":74,"geoPoint":78,"contacts":7},"Duke Univ Med Ctr","Durham","North Carolina","277103499",{"type":29,"coordinates":75},[76,77],-78.89862,35.99403,{"lat":77,"lon":76},[80],{"name":81,"class":82},"Upjohn","INDUSTRY","100053830","phase-3-the-safety-and-effectiveness-of-methylprednisolone-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-in-children-with-aids-100053830",false,"NCT00000741","The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS","A Controlled Randomized Trial to Study the Efficacy of Adjunctive Methylprednisolone for the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Pediatric AIDS Patients","Inclusion Criteria\n\nConcurrent Medication:\n\nAllowed:\n\n* Recombinant erythropoietin and any FDA-approved cytokine for management of anemia.\n* Antiretroviral agents.\n\nPatients must have:\n\n* Documented HIV infection.\n* PCP.\n* No more than 36 hours of prior primary therapy for confirmed or presumed PCP.\n\nPrior Medication:\n\nAllowed:\n\n* Up to 35 hours of primary therapy for confirmed or presumed PCP.\n\nExclusion Criteria\n\nCo-existing Condition:\n\nPatients with the following symptoms and conditions are excluded:\n\n* Demonstrated intolerance to steroids.\n* Requirement for steroids at greater than physiological doses for other medical conditions.","ALL","28 Days","2 Years",{"count":94,"type":95},0,"ACTUAL","INTERVENTIONAL",[98],"PHASE3","To determine the effect of methylprednisolone on respiratory failure in HIV-infected patients with presumed or confirmed pneumocystis carinii pneumonia who are stratified for presence or absence of respiratory failure at the time of randomization to the study.",[101,102],"Pneumonia, Pneumocystis Carinii","HIV Infections",[104,105,11],"Pneumonia, Pneumocystis carinii","Acquired Immunodeficiency Syndrome","WITHDRAWN","2021-10-27",{"date":109,"type":95},"2021-11-04",{"name":5,"class":6},6]